Search - Normandie Université Access content directly

Filter your results

36 Results
authFullName_s : Catherine Thieblemont

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill , Catherine Thieblemont , Lucie Oberic , Anne Moreau , Krimo Bouabdallah , et al.
New England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
Journal articles hal-02329536v1
Image document

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies

Pierre Sujobert , Yannick Le Bris , Laurence de Leval , Audrey Gros , Jean Philippe Merlio , et al.
HemaSphere, 2019, 3 (1), pp.e169. ⟨10.1097/HS9.0000000000000169⟩
Journal articles hal-02397399v1
Image document

Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party

Johannes Schetelig , Patrice Chevallier , Michel van Gelder , Jennifer Hoek , Olivier Hermine , et al.
Bone Marrow Transplantation, 2020, 56 (3), pp.605 - 613. ⟨10.1038/s41409-020-01069-w⟩
Journal articles inserm-03549845v1

Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study

Asma Beldi-Ferchiou , Jean-Philippe Jais , Herve Ghesquieres , Rene Olivier Casasnovas , Hervé Tilly , et al.
British Journal of Haematology, 2023, British Journal of Haematology, 201 (2), pp.256-266. ⟨10.1111/bjh.18642⟩
Journal articles hal-04224835v1
Image document

Deep learning FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma

Nicolò Capobianco , Michel Meignan , Anne-Ségolène Cottereau , Laetitia Vercellino , Ludovic Sibille , et al.
Journal of Nuclear Medicine, 2021, 62 (1), pp.30-36. ⟨10.2967/jnumed.120.242412⟩
Journal articles hal-03089357v1

Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma

Sydney Dubois , Philippe Ruminy , Elodie Bohers , Pierre‐julien Viailly , Liana Veresezan , et al.
Clinical Case Reports, 2021, 9 (8), ⟨10.1002/ccr3.4504⟩
Journal articles hal-03671528v1
Image document

A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma

Catherine Thieblemont , Loic Chartier , Ulrich Dührsen , Umberto Vitolo , Sally Barrington , et al.
Blood Advances, 2022, 6 (23), pp.5995-6004. ⟨10.1182/bloodadvances.2021006923⟩
Journal articles inserm-03924551v1

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

Marie-Hélène Delfau-Larue , Wolfram Klapper , Françoise Berger , Fabrice Jardin , Josette Brière , et al.
Blood, 2015, 126 (5), pp.604-611. ⟨10.1182/blood-2015-02-628792⟩
Journal articles hal-02331700v1

Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies

Aurélie Cabannes-Hamy , Frédéric Peyrade , Fabrice Jardin , Jean-François Emile , Vincent Delwail , et al.
Cancer Medicine, 2018, 7 (3), pp.539-548. ⟨10.1002/cam4.1139⟩
Journal articles hal-02329451v1

Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA

Roch Houot , Carole Soussain , Hervé Tilly , Corinne Haioun , Catherine Thieblemont , et al.
Annals of Oncology, 2016, 27 (7), pp.1349-50. ⟨10.1093/annonc/mdw138⟩
Journal articles hal-01295653v1
Image document

Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC

David Beauvais , Emmanuel Bachy , André Baruchel , Jacques-Olivier Bay , Denis Caillot , et al.
Bulletin du Cancer, 2021, 108 (7-8), pp.725-729. ⟨10.1016/j.bulcan.2020.10.017⟩
Journal articles inserm-03349011v1
Image document

Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years

Maxime Jullien , Benoit Tessoulin , Hervé Ghesquières , Lucie Oberic , Franck Morschhauser , et al.
Cancers, 2021, 13 (18), pp.4503. ⟨10.3390/cancers13184503⟩
Journal articles inserm-03540506v1

A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma

Bertrand Coiffier , Catherine Thieblemont , Sophie de Guibert , Jehan Dupuis , Vincent Ribrag , et al.
British Journal of Haematology, 2016, 173 (5), pp.722-730. ⟨10.1111/bjh.13992⟩
Journal articles hal-01295660v1

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study

Fabrice Jardin , Jean-Philippe Jais , Thierry-Jo Molina , Françoise Parmentier , Jean-Michel Picquenot , et al.
Blood, 2010, 116 (7), pp.1092-1104
Journal articles ensl-00816038v1

French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up

Jérôme Paillassa , Edouard Cornet , Stephanie Noel , Cécile Tomowiak , Aline Schmidt , et al.
Blood, 2019, 134 (Supplement_1), pp.1537-1537. ⟨10.1182/blood-2019-127560⟩
Journal articles hal-02416164v1

Axicabtagene ciloleucel in large B cell lymphoma ineligible for autologous stem cell transplantation: the phase 2 ALYCANTE trial

Roch Houot , Emmanuel Bachy , Guillaume Cartron , François-Xavier Gros , Franck Morschhauser , et al.
Nature Medicine, 2023, ⟨10.1038/s41591-023-02572-5⟩
Journal articles hal-04212634v1
Image document

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

Franck Morschhauser , Gilles Salles , Steven Le Gouill , Hervé Tilly , Catherine Thieblemont , et al.
Blood, 2018, 132 (14), pp.1486 - 1494. ⟨10.1182/blood-2018-05-853499⟩
Journal articles hal-01928199v1

A Molecular Classifier Increased the Accuracy of Lymphoma Diagnosis By Expert Pathologists in the Diffuse Large B-Cell Lymphoma Gained Trial from the Lysa

Amine Moslemi , Victor Bobée , Paul Blanc-Durand , Fanny Drieux , Fabienne Desmots-Loyer , et al.
Blood, 2021, 138 (Supplement 1), pp.3495. ⟨10.1182/blood-2021-152144⟩
Journal articles hal-03770121v1

Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA.

A. Trebouet , T. Marchand , R. Lemal , Emmanuel Gyan , Florence Broussais-Guillaumot , et al.
Annals of Oncology, 2013, 24 (10), pp.2612-8. ⟨10.1093/annonc/mdt282⟩
Journal articles inserm-00869892v1
Image document

TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia

Grégory Lazarian , Floriane Theves , Myriam Hormi , Rémi Letestu , Virginie Eclache , et al.
American Journal of Hematology, 2022, 97 (4), pp.E159-E162. ⟨10.1002/ajh.26479⟩
Journal articles hal-03557401v1
Image document

Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up

Jérôme Paillassa , Edouard Cornet , Stéphanie Noël , Cécile Tomowiak , Stéphane Lepretre , et al.
Blood Cancer Journal, 2020, 10 (5), pp.62. ⟨10.1038/s41408-020-0328-z⟩
Journal articles inserm-03495791v1

Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia

Edouard Cornet , Cécile Tomowiak , Aline Tanguy-Schmidt , Stéphane Leprêtre , Jehan Dupuis , et al.
British Journal of Haematology, 2014, 166 (3), pp.390 - 400. ⟨10.1111/bjh.12908⟩
Journal articles hal-01690636v1

CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria

Jerome Paillassa , Roberta Di Blasi , Sylvie Chevret , Sophie Bernard , Michael Darmon , et al.
Blood, 2019, 134 (1), ⟨10.1182/blood-2019-129532⟩
Journal articles hal-03605011v1

Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French network

Laurence Schenone , Caroline Houillier , Marie Laure Tanguy , Sylvain Choquet , Kossi Agbetiafa , et al.
Bone Marrow Transplantation, 2022, 57 (6), pp.966-974. ⟨10.1038/s41409-022-01648-z⟩
Journal articles hal-03703797v1
Image document

Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study

Emmanuel Bachy , Roch Houot , Pierre Feugier , Krimo Bouabdallah , Reda Bouabdallah , et al.
Blood, 2022, 139 (15), pp.2338-2346. ⟨10.1182/blood.2021013526⟩
Journal articles hal-03679319v1

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Catherine Thieblemont , Hervé Tilly , Maria Gomes Da Silva , Rene-Olivier Casasnovas , Christophe Fruchart , et al.
Journal of Clinical Oncology, 2017, 35 (22), pp.2473-2481. ⟨10.1200/JCO.2017.72.6984⟩
Journal articles hal-01609346v1
Image document

Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial

Benoit Tessoulin , David Chiron , Catherine Thieblemont , Lucie Oberic , Kamal Bouadballah , et al.
Bone Marrow Transplantation, 2021, 56 (7), pp.1700-1709. ⟨10.1038/s41409-020-01198-2⟩
Journal articles hal-03203334v1
Image document

Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group

Steven Le Gouill , Asma Beldi-Ferchiou , Marion Alcantara , Victoria Cacheux , Violaine Safar , et al.
Lancet Haematology, 2020, 7 (11), pp.e798-e807. ⟨10.1016/S2352-3026(20)30291-X⟩
Journal articles hal-03012903v1

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study

Jean-Marie Michot , Danielle Canioni , Henda Driss , Laurent Alric , Patrice Cacoub , et al.
American Journal of Hematology, 2015, 90 (3), pp.197-203. ⟨10.1002/ajh.23889⟩
Journal articles hal-03213703v1

Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older

Lucie Oberic , Frédéric Peyrade , Mathieu Puyade , Christophe Bonnet , Peggy Dartigues-Cuillères , et al.
Journal of Clinical Oncology, 2021, 39 (11), pp.1203-1213. ⟨10.1200/JCO.20.02666⟩
Journal articles hal-03218435v1